Erika P. Hamilton

ScholarGPS® ID: 79167693965137

Affiliation

Sarah Cannon Research Institute, Nashville, United States

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

249

Predicted Citations

7,323

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Comparison of expert treatment recommendations versus community healthcare providers: Analysis from an online decision support tool for metastatic breast cancer. (journal article) Mayer, Erica L. \| Jhaveri, Komal L. \| Hamilton, Erika P. \| Kalinsky, Kevin \| Constanzo, Jerfiz D. \| Rosenthal, Kristen M. \| Spring, Laura Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1053-1053 (2024). 10.1200/JCO.2024.42.16_suppl.1053 Cite \| Source
Study of ELU001, a C’Dot drug conjugate (CDC) targeting folate receptor α (FRα) overexpressing solid tumors. (journal article) Ma, Wen Wee \| Tolcher, Anthony W. \| Perez, Cesar Augusto \| Wahner Hendrickson, Andrea Elisabeth \| Orr, Douglas W. \| Murciano-Goroff, Yonina R. \| Anders, Carey K. \| Hamilton, Erika P. \| Swisher, Elizabeth M. \| Mathews, Cara Amanda \| ... \| Bayever, Eliel Journal of Clinical Oncology, volume 42, issue 16_suppl, pages TPS3173-TPS3173 (2024). 10.1200/JCO.2024.42.16_suppl.TPS3173 Cite \| Source
Preliminary results from a phase 1 study of AC699, an orally bioavailable chimeric estrogen receptor degrader, in patients with advanced or metastatic breast cancer. (journal article) Patel, Manish R. \| Layman, Rachel M. \| Danso, Michael A. \| Cosgrove, David \| Zettler, Marjorie E. \| Pehlivan, Katherine C. \| Hamilton, Erika P. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 3074-3074 (2024). 10.1200/JCO.2024.42.16_suppl.3074 Cite \| Source
First-in-human phase 1/2a study of the first-in-class, next-generation CDK4-selective inhibitor PF-07220060 + endocrine therapy (ET): Updated safety data in patients with HR+/HER2− mBC. (journal article) Giordano, Antonio \| Sharma, Manish \| Williams, Anja \| Schmid, Peter \| Flores Diaz, Diana Fabiola \| Magallanes, Manuel \| Xu, Binghe \| Yan, Min \| Howell, Sacha Jon \| Hamilton, Erika P. \| ... \| Yap, Timothy A. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 3108-3108 (2024). 10.1200/JCO.2024.42.16_suppl.3108 Cite \| Source
Updated safety and antitumor activity of BB-1701 from study 101 in the multiple dose level cohort of patients with locally advanced/metastatic HER2-low expressing breast cancer. (journal article) Ma, Fei \| Guan, Xiaoxiang \| Wang, Jingfen \| Yao, Herui \| Wang, Xian \| Hamilton, Erika P. \| Shi, Yehui \| Liang, Xinjun \| Xu, Nong \| Tang, Huoling \| ... \| Munster, Pamela N. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1110-1110 (2024). 10.1200/JCO.2024.42.16_suppl.1110 Cite \| Source
Tucatinib and trastuzumab for previously treated HER2−mutated metastatic breast cancer (SGNTUC−019): A phase 2 basket study. (journal article) Okines, Alicia Frances Clare \| Curigliano, Giuseppe \| Mizuno, Nobumasa \| Oh, Do-Youn \| Rorive, Andree \| Soliman, Hatem Hussein \| Takahashi, Shunji \| Bekaii-Saab, Tanios S. \| Hamilton, Erika P. \| Monk, Bradley J. \| ... \| Pohlmann, Paula R Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1105-1105 (2024). 10.1200/JCO.2024.42.16_suppl.1105 Cite \| Source
Real-world (RW) elacestrant use patterns and therapeutic outcomes in patients (pts) with hormone receptor-positive (HR+)/HER2-negative advanced breast cancer (aBC). (journal article) Lloyd, Maxwell Roger \| Ali, Azka \| Weipert, Caroline M. \| Solomon, Sheila R \| Saha, Jayati \| Lipsyc-Sharf, Marla \| Hamilton, Erika P. \| Kalinsky, Kevin \| Bardia, Aditya \| Zhang, Nicole \| Wander, Seth Andrew Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1071-1071 (2024). 10.1200/JCO.2024.42.16_suppl.1071 Cite \| Source
Elacestrant in various combinations in patients (pts) with estrogen receptor-positive (ER+), HER2-negative (HER2-) locally advanced or metastatic breast cancer (adv/mBC): Preliminary data from ELEVATE, a phase 1b/2, open-label, umbrella study. (journal article) Rugo, Hope S. \| O'Shaughnessy, Joyce \| Cortes, Javier \| Bardia, Aditya \| Hamilton, Erika P. \| Hurvitz, Sara A. \| Kaklamani, Virginia G. \| Romero, Paula Muñoz \| Vallespir, Bartomeu Pizà \| Wasserman, Tomer \| ... \| Tolaney, Sara M. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1069-1069 (2024). 10.1200/JCO.2024.42.16_suppl.1069 Cite \| Source
Elacestrant in combination with abemaciclib in patients (pts) with brain metastasis from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer: Preliminary data from ELECTRA, an open-label, multicenter, phase 1b/2 study. (journal article) Ibrahim, Nuhad K. \| Hamilton, Erika P. \| Kim, Sung-Bae \| Im, Young-Hyuck \| Seguí, Elia \| García-Sáenz, Jose A. \| Di Sanzo, Alessandro \| Vallespir, Bartomeu Pizà \| Domínguez Lizarbe, Manuel \| Wasserman, Tomer \| ... \| Ciruelos, Eva Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1064-1064 (2024). 10.1200/JCO.2024.42.16_suppl.1064 Cite \| Source
H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive (ER+), HER2 negative (–) breast cancer (BC). (journal article) Hamilton, Erika P. \| Pluard, Timothy J. \| Wang, Judy S. \| Morikawa, Aki \| Johnston, Stephen R. D. \| Dees, Elizabeth Claire \| Vaklavas, Christos \| Armstrong, Anne C. \| Munster, Pamela N. \| Unni, Nisha \| ... \| Juric, Dejan Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1015-1015 (2024). 10.1200/JCO.2024.42.16_suppl.1015 Cite \| Source
Targeted interventions to address local challenges in HR+/HER2- and HER2+ breast cancer treatment in community-based settings. (journal article) Mahtani, Reshma L. \| Hamilton, Erika P. \| Storey, Janet \| Dewald, Ilona \| Dooyema, Samuel \| Carter, Jeffrey D. \| Heggen, Cherilyn \| McKinnon, Kelly E. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e23213-e23213 (2024). 10.1200/JCO.2024.42.16_suppl.e23213 Cite \| Source
H3B-6545 + palbociclib in patients (pts) with locally advanced/metastatic estrogen receptor-positive (ER+), HER2 negative (–) breast cancer (BC). (journal article) Johnston, Stephen R. D. \| Pluard, Timothy J. \| Wang, Judy S. \| Hamilton, Erika P. \| Song, Tingting \| Rong, Yuanxin \| Yamaguchi, Kohei \| Juric, Dejan Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1051-1051 (2024). 10.1200/JCO.2024.42.16_suppl.1051 Cite \| Source
DESTINY-Breast07: Dose-expansion interim analysis of T-DXd monotherapy and T-DXd + pertuzumab in patients with previously untreated HER2+ mBC. (journal article) Andre, Fabrice \| Hamilton, Erika P. \| Loi, Sherene \| Anders, Carey K. \| Schmid, Peter \| Stroyakovskiy, Daniil \| Villanueva, Rafael \| Pedrini, Jose Luiz \| Doval, Dinesh Chandra \| Zurawski, Bogdan \| ... \| Jhaveri, Komal L. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1009-1009 (2024). 10.1200/JCO.2024.42.16_suppl.1009 Cite \| Source
Short-term risk of recurrence in patients (pts) with HR+/HER2− early breast cancer (EBC) treated with endocrine therapy (ET) in randomized clinical trials (RCTs): A meta-analysis. (journal article) Curigliano, Giuseppe \| Ciruelos, Eva \| Kalinsky, Kevin \| Proudman, David \| Nellesen, Dave \| Lopez, Priscilla \| Kaufhold, Samantha \| Shane, Olivia \| Kwok, Adrienne \| Ganapathy, Vaidyanathan \| ... \| Hamilton, Erika P. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 541-541 (2024). 10.1200/JCO.2024.42.16_suppl.541 Cite \| Source
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer (journal article) Goetz, Matthew P. \| Hamilton, Erika P. \| Campone, Mario \| Hurvitz, Sara A. \| Cortes, Javier \| Johnston, Stephen \| Llombart-Cussac, Antonio \| Kaufman, Peter A. \| Toi, Masakazu \| Jerusalem, Guy \| ... \| Martin, Miguel Clinical Cancer Research, volume 30, issue 10, pages 2233-2244 (2024). 10.1158/1078-0432.CCR-22-3573 Cited by (3) \| Cite \| Source
559 Results from the phase 1 dose escalation study of XMT-1592, a dolasynthen NAPI2B-directed antibody-drug conjugate (ADC) (conference) Hamilton, Erika P \| Papadopoulos, Kyriakos P \| Barve, Minal \| Lakhani, Nehal \| Burns, Timothy F \| Burger, Robert A \| Reske, Adi \| Wekheye, Kelley \| Tolcher, Anthony ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.671 Cite \| Source
372 TABLET: food effect study of niraparib tablets in patients with advanced solid tumours (conference) Richardson, Debra L \| Falchook, Gerald \| Donald Harvey, R \| Sharma, Manish \| Hafez, Navid \| Hamilton, Erika \| Patnaik, Amita \| Piha-Pau, Sarina A \| Barve, Minal \| Wise-Draper, Trisha \| ... \| Potocka, Elizabeth ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.499 Cite \| Source
187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study (conference) Sehouli, Jalid \| Vergote, Ignace \| Hamilton, Erika \| Fidalgo, Alejandro Pérez \| Gorp, Toon Van \| Scambia, Giovanni \| Klat, Jaroslav \| Levy, Tally \| Welch, Stephen \| Richardson, Debra L \| ... \| Makker, Vicky ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.20 Cited by (2) \| Cite \| Source
Breaking Barriers: Integrating Germline Testing With Oncology Care (journal article) Shastry, Mythili \| Hammer, Marilyn E. \| McKenzie, Andrew J. \| Hamilton, Erika P. JCO Oncology Practice, volume 20, issue 2, pages 157-159 (2024). 10.1200/OP.23.00627 Cite \| Source
TP020/#1513 First-in-human phase 1/2 study of ubamatamab, a MUC16XCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer (conference) Moore, Kathleen \| Bouberhan, Sara \| Hamilton, Erika \| Liu, Joyce \| O’Cearbhaill, Roisin \| O’Malley, David \| Papadimitriou, Konstantinos \| Schröder, David \| Nieuwenhuysen, Els Van \| Yoo, Suk-Young \| ... \| Miller, Elizabeth IGCS 2023 Annual Meeting Abstracts (2023) 10.1136/ijgc-2023-IGCS.480 Cite \| Source